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Fluorescence imaging has become a standard in many clinical applications, such as tumor 
and vasculature imaging.1 One application that is becoming more prominent in cancer 
treatment is fluorescence-guided surgery (FGS). Currently, FGS allows surgeons the 
ability to visually navigate tumors and tissue structures intraoperatively.2 As a result, they 
can remove tumor more efficiently while maintaining critical structures within the patient, 
creating better outcomes and lower recovery times.2 However, background fluorescence 
and inability to localize depth create challenges when determining resection boundaries.  
Different techniques, such as spatially modulating the illumination and imaging at longer 
light wavelengths, have been developed to accurately localize position and to maximize 
contrast of key structures at greater penetration depths in surgeries.3,4 However, combining 
these two techniques offers an opportunity to capitalize on their respective advantages in 
fluorescence imaging. 
In this work, we develop instrumentation combining two cutting-edge imaging 
methodologies; spatial frequency domain imaging (SFDI) and short-wave infrared (SWIR) 
fluorescence, and evaluate the capacity of this combination to improve image quality. 
Using conventional flat light imaging and SFDI, images of a fluorescent tube submerged 
in a liquid phantom were taken in the standard “first window” of the near-infrared (NIR-I) 
and the SWIR. By comparing resolution and maximum signal of the resulting images, we 
determined whether SFDI in the SWIR can improve fluorescence imaging for surgery such 




We found that SFDI in the SWIR localizes depth and increases contrast by removing 
background fluorescence. When compared to NIR-I, SWIR SFDI is not as depth sensitive 
but can capture deeper structures. These results show that implementing SFDI can 
significantly improve current biomedical applications of SWIR imaging. Next steps for 
SWIR SFDI include analyzing the effects from altering the optical properties of the 
phantom, investigating the interaction between multiple fluorescent objects, and 
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Surgical intervention is one of the most common treatments for all types of cancer, 
involved in just over two-thirds of all first course treatment from 2007 to 2016.5 Surgery 
involves excising the tumor and surrounding margins, or immediate tissue area around the 
tumor location, such that all cancer cells are removed from the area.2 However, cancer cells 
are often missed, thus increasing the occurrences of positive margins.6,7 In some 
indications, such as breast cancer surgery, a positive margin result usually demands a re-
excision operation which subjects the patient to increased risk of infection, physical pain, 
and emotional distress.2,7,8 Hence, it is critical that surgery be successful in removing the 
tumor, and leaving negative margins the first time.  
For diagnosis, staging, and preoperative planning, physicians use imaging modalities such 
as computed tomography (CT), magnetic resonance imaging (MRI), single-photon 
emission computed tomography (SPECT), and positron emission tomography (PET).9,10 
While operating on the patient, however, most of these modalities are not viable.10 
Although there are currently intraoperative CT and MRI capabilities, they are not widely 
used and are not feasible in low-cost settings.11–13 Thus, many surgeons currently rely on 
visual inspection or palpation to distinguish between healthy and cancerous tissue, rather 
than real-time quantitative information.10,14–16 This increases the chance to overestimate 
the surgical margin, decreasing patient recovery rate, or underestimate it, leaving positive 
margins.2  
Optical imaging techniques, specifically those utilizing fluorescence, offer significant 
advantages over other imaging modalities in providing cost-efficient real time imaging 




fluorophores, fluorescent chemical compounds which emit light after being excited by light 
of a shorter wavelength.2 These fluorophores are injected into the patient and illuminated 
by an external light source.2 The emitted light from the fluorophores is then collected using 
a camera sensitive to these fluorescent wavelengths.2,17 The key advantages fluorescence 
imaging offers over other imaging modalities are non-ionizing energy sources (which 
reduces overall cell damage), detailed optical visualization of subsurface tissue structures, 
and low cost.6,16,18 
In this context, broad research efforts have shown that fluorescence-guided surgery (FGS) 
can improve patient outcomes, and the technique has been approved by the FDA for some 
surgical indications.2,19,20 However, a major limitation of current FGS approaches is the 
inability to determine the depth from the tissue surface of an embedded fluorescing object, 
which is often a critical factor in determining resection boundaries.21 Furthermore, false-
positive and -negative readings in FGS can be caused by tissue autofluorescence and 
fluorescence in the immediate vicinity of tumor cells.22 These false positives can lead to 
excessive damage to the patient’s important structures, causing pain and loss of function 
after the surgery.13 
Previous research has demonstrated that short-wave infrared (SWIR) fluorescence imaging 
has the potential to improve upon current fluorescence imaging in the “first window” of 
the near-infrared (NIR-I).3 Due to its unique scattering and absorption properties in tissue, 
SWIR fluorescence can be imaged at deeper depths and with greater contrast.3,23 
Unfortunately, SWIR flat light imaging alone is unable to localize depth from the tissue 
surface as there is no mechanism to filter fluorescence from deeper structures. However, 




selectively filtering out fluorescence below a threshold depth.21 SFDI has been shown to 
improve depth localization and filter background fluorescence in the NIR-I.21 Nevertheless, 
not much is known about the potential advantages of combining SWIR with SFDI. Hence, 
this thesis looks at how SWIR SFDI compares with the current state-of-the-art and what 
improvements it can offer. 
In the remainder of this thesis, we look at an overview of SWIR imaging and SFDI in 
Section 2. In Section 3, we perform spectroscopy and phantom imaging studies to 
determine what fluorescent dyes can be imaged in the SWIR. In Section 4, we perform an 
experiment to compare NIR-I and SWIR SFDI. We discuss the results in Section 5 and 
conclude in Section 6. 
2. Background 
In this section, we give an overview of the optical windows fluorescence imaging currently 
takes place in and how they influence resolution and depth penetration. We also describe 





2.1 SWIR imaging overview 
 
Figure 1: Standard light wavelengths used in fluorescent imaging. The spectrum is made 
up of the visible and near-infrared wavelengths. Two key windows that dominate 
fluorescence imaging are the first and second windows of the near-infrared (NIR-I and 
NIR-II/SWIR, respectively). 
 
Figure 1 shows the light spectrum in which most fluorescence imaging takes place. 
Currently, the majority of fluorescence imaging applications use the NIR-I light spectrum 
because human tissue has less autofluorescence and background absorbance in the NIR-I 
than in the visible spectrum (380 – 700 nm).24–29 However, light in the NIR-I undergoes 
significant scatter, which degrades image resolution as it blurs the object.15,21 Absorption, 
the other major obstacle, reduces the signal of the excited fluorescent object, decreasing 
contrast from background noise.30 Currently, fluorescence imaging attempts to maximize 
signal by imaging in wavelengths between the absorbance peaks of key biological 
components like hemoglobin, lipids, and water.15 These wavelengths make up NIR-I (650 
– 950 nm).31  
Light emitted in NIR-I is highly scatter-sensitive in tissue which contributes to low contrast 
images with significant background fluorescence.24,32–35 However, the introduction of 




accelerating research efforts to image fluorescence in this regime.3,36 Light emitted in 
SWIR is less scattered in tissue and thus penetrates further before becoming diffuse.31 
Consequently, SWIR imaging has become an emerging topic in the biomedical optics 
field.26,32,36,37 Although light in the SWIR is more sensitive to absorption from water and 
lipids, the overall attenuation of emitted light is much lower than the NIR-I or visible 
wavelength regimes due to significantly reduced scattering.3,38 Thus, SWIR imaging has 
greater potential to image structures at deeper depths and with higher contrast than imaging 
in the NIR-I.  
However, background fluorescence emitted from deeper fluorescent structures still poses 
a challenge as it can interfere with the image contrast of structures closer to the surface.23,39 
Moreover, depth information for the fluorescent object can be difficult to determine with 
flat light imaging alone due to light scatter in non-homogeneous mediums, such as tissue.21 
Hence, current SWIR flat light imaging faces similar limitations as NIR-I flat light 
imaging. 
2.2 SFDI overview 
Developed as an alternative to near-infrared spectroscopy (NIRS), SFDI is a non-contact 
imaging approach that can rapidly quantify tissue’s optical properties and concentrations 
of chromophores (e.g., hemoglobin, myoglobin, and cytochrome) over a wide field-of-
view.4,40 This method is spatially dependent, not time-dependent, and is typically 
conducted in the NIR-I.34,41 To perform SFDI, the user projects a repeating spatial pattern 
of light onto the tissue surface (see Figure 2), and a camera records the emitted light pattern 
remitted from the tissue.4 The repeating spatial pattern of light, formally known as spatially 




spatial frequency of the pattern.42 By measuring the frequency-dependent reflectance of 
tissue, one can derive the absorption and reduced scattering properties.4,34,42,43 By 
evaluating these optical properties at different wavelengths of light, the concentrations of 
common tissue chromophores can be calculated.44 This technique, known as quantitative 
reflectance imaging, has been used to monitor tissue health to improve clinical outcomes.4 
 
Figure 2: Flat light vs. spatially modulated illumination of tissue. 
 
In addition to quantitative reflectance imaging, SFDI has recently been used to image 
fluorescent markers.21,45,46 Recent research has demonstrated that SFDI can suppress 
fluorescence from deeper structures and improve signal contrast for superficial structures.21 
By changing the spatial frequency of the illumination, fluorescence can be localized in 
relation to the surface.21 Moreover, SFDI significantly reduces diffuse fluorescence from 




Hence, fluorescence imaging with SFDI significantly improves signal contrast from the 
background and localizes depth of fluorescent structures. 
Although SFDI is an effective technique for fluorescence imaging, the optical window in 
which emitted light is recorded still determines how much signal can be detected. Image 
processing for SFDI depends on the resolution of the spatial pattern emitted from the 
fluorescent structure.44,46 As the spatial pattern becomes less distinct due to diffusion, the 
processed image of the fluorescent object increasingly fades into the background. As a 
result, light scatter and spatial frequency determine the ultimate depth of pattern recovery. 
Since SFDI is currently used in the NIR-I, the ultimate depth is relatively shallow.21 
Choosing wavelengths that scatter less in tissue (such as those in the SWIR) can possibly 
extend the range SFDI can reach while maintaining a similar depth sensitivity. 
3. Evaluating SWIR fluorescence from commonly used fluorescent dyes 
Until recently, SWIR fluorescence imaging was typically performed with specialized 
molecules designed and made by a handful of labs.3,47 These fluorophores were difficult to 
obtain and may never be approved for human use.3,47 In response to recent reports that 
some commonly used NIR-I fluorophores show signal in the SWIR, we designed a set of 
experiments to evaluate the SWIR signal of a large catalogue of NIR-I fluorophores. After 
determining the spectra of the different near-infrared fluorophores, a phantom imaging 
study was performed to determine feasibility with wide field imaging. 
3.1 SWIR spectroscopy imaging with conventional dyes 
There are a limited number of fluorophores that are marketed to specifically emit in the 




available and have been demonstrated to emit light in the SWIR region, even though their 
emission peaks are in the NIR-I region.3,23,47 As a result, a comparative spectroscopy study 
in the SWIR wavelengths was performed with eight common red/NIR-I fluorophores and 
one SWIR-specific fluorophore. 
The commercial red/NIR-I fluorophores studied were: indocyanine green (ICG, Chem-
Impex Int’l. Inc.), methylene blue (Sigma-Adrich), LI-COR’s IRDye 680RD, IRDye 
700DX, and IRDye 800CW (LI-COR Biosciences, Inc.), and Alexa Fluor (AF) 
fluorophores AF 633, AF 647, and AF 750 (ThermoFisher Scientific). All of these 
fluorophores are either FDA-approved for clinical use (ICG and methylene blue), 
undergoing clinical investigation (IRDye 800CW), or used extensively for laboratory 
imaging (Alexa Fluor series). A SWIR-specific fluorophore, IR-m1050 (Nirmidas Biotech, 
Inc.), was also studied for comparison purposes against the red/NIR-I fluorophores. 
 
Figure 3: Absorbance spectrums for all fluorophores tested. Fluorophores were organized 
based on peak, with AF633 having the shortest wavelength absorbance peak and ICG 
having the longest. The laser diode bars indicate the wavelengths which will excite the 




In order to prepare samples for the spectroscopy study, each fluorophore was dissolved or 
diluted in a clear solvent iteratively until it was estimated to be slightly above a clinically 
relevant concentration of 1 𝜇M.48 Aside from ICG, which was dissolved in distilled water, 
all other fluorophores were dissolved in phosphate-buffered solution (PBS). For each 
sample, 3 mL of a fluorophore solution was pipetted into a clear 3-mL plastic cuvette. 
Additionally, distilled water and PBS samples were created for absorbance background 
subtraction. The absorbance spectrums of these fluorophore solutions and control solutions 
were then measured using the Varian Cary® 50 Bio UV-VIS spectrophotometer (see 
Figure 3). A fluorophore’s peak absorbance was used to calculate the concentration. In 
order to correct for background, the absorbance of the solvent (either PBS or distilled 
water) was measured at the same wavelength as the fluorophore’s peak and then subtracted 
from the fluorophore’s absorbance: 
𝐴𝑐𝑜𝑟𝑟𝑒𝑐𝑡𝑒𝑑 = 𝐴𝑓𝑙𝑢𝑜𝑟𝑜𝑝ℎ𝑜𝑟𝑒 − 𝐴𝑠𝑜𝑙𝑣𝑒𝑛𝑡 (1) 
From the corrected absorbance (𝐴𝑐𝑜𝑟𝑟𝑒𝑐𝑡𝑒𝑑, unitless), the concentration of the solution (c, 





where 𝜖 is the extinction coefficient at the fluorophore’s peak absorbance wavelength 
(M−1cm−1) and b is the path length of the sample (cm). The path length of the sample is 1 
cm, and the extinction coefficient used for each fluorophore was either found in literature 
or provided by the manufacturer (see Table A1 in Appendix). From these measured 
concentrations, the fluorophore solutions were then iteratively diluted and remeasured until 





Figure 4: a) Picture of the spectrograph assembly. b) Diagram of the spectroscopy 
experiment. The fluorophore sample was excited by the respective laser in a light tight 
chamber and collected by the spectrograph assembly. 
 
Figure 4 shows the setup of the spectroscopy experiment. After the solutions were 
confirmed to be 1 𝜇M, each sample cuvette was then placed in a 3D printed holder inside 
a light tight chamber, where it interfaced with a 200 𝜇m illumination fiber connected to the 
laser source and an optic fiber connected to the spectrograph assembly. The face of the 
illumination fiber was placed against the cuvette to limit reflection off the plastic. Every 
fluorophore sample was excited by each of the five lasers in the following order: 635, 730, 
760, 785, and 670 nm (World Star Tech). The laser power density for each laser was 
maintained to be around 21 
𝑚𝑊
𝑐𝑚2
 throughout collection to ensure that laser output did not 




Spectra Pro SP2150 (Princeton Instruments), with a 300-grooves/mm grating centered at a 
wavelength of 1200 nm, attached to an InstaSpec IR spectroscopy camera (Newport 
Corporations). The InstaSpec camera is a 1024 x 256 pixel InGaAs charged-coupled device 
cooled to -50 °C. The light collected from the optic fiber passed through an 1100 nm 
dichroic long pass filter before entering the spectrograph. The camera settings for the study 
were set to a gain of 800 and an exposure time of 40 ms. The data collected from the camera 
was vertically binned (each column was summed up) to report the emission intensity at 
each wavelength value in the spectra. To determine the wavelengths being measured as 
well as the change in wavelength per pixel, the spectrograph assembly was calibrated using 
a mercury lamp. 
For each laser-fluorophore combination, 10 SWIR fluorescence frames (laser on) and 10 
background frames (laser off) were collected. In order to minimize noise, these frames 
were median-filtered to create one SWIR fluorescence frame and one background frame. 
The background frame was then subtracted from the SWIR fluorescence frame to remove 
any background signal. The background-subtracted emission spectra were normalized to 
the highest emission intensity (ICG excited at 785 nm) and reported in Figure 5. From these 
spectra, we were able to see fluorescence in the SWIR. Specifically, we can see the 





Figure 5: SWIR emission spectra for tested fluorophores. Each panel is organized by the 
laser used to excite the fluorophore. 
 
Figure 6: Heat map of integrated fluorescence for all sample-laser combinations. The map 
is normalized to ICG excited by the 785 nm laser. 
 
The integrated fluorescence for each sample spectra in Figure 5 was then computed 




the highest fluorophore integrated intensity (ICG excited at 785 nm) and reported in Figure 
6. This heat map depicts the brightness of the fluorophores in the SWIR wavelengths in 
relation to each other. ICG, IR-m1050, IRDye 800CW, and AF 750 were able to be 
detected when excited with any laser source, but they were the brightest when excited with 
the 760 nm and 785 nm. This is expected because their peak absorbances coincide with 
these longer laser wavelengths. From these results, we were able to determine laser-
fluorophore pairs that best emit in the SWIR. 
3.2 SWIR phantom imaging with conventional dyes 
In order to capture the behavior of these dyes in more application-based settings, wide-
field imaging of phantoms with serially diluted concentrations was performed. The 
experimental setup, depicted in Figure 7, consisted of a laser source fiber coupled to a 
condenser lens to illuminate the phantom and a NIRvana 640 InGaAs camera (Princeton 
Instruments) with an 1100-nm long pass dichroic filter to capture fluorescence emission.  
 




Tissue-simulating phantoms were created in 5-mL liquid wells containing the selected 
fluorophore, 1% intralipid (to mimic tissue scattering properties), and 1% whole blood (to 
mimic tissue absorption properties) in PBS.50 The concentration of the fluorophore varied 
between 5 𝜇𝑀 to 19 𝑛𝑀 in 50% serial dilutions. The laser selected for each fluorophore 
was determined by the results of the spectroscopy study. AF 633 and AF 647 were excited 
by the 635 nm laser. IRDye 680RD, IRDye 700DX, and methylene blue were excited by 
the 670 nm laser. AF 750, IRDye 800CW, ICG, and IR-m1050 were excited using the 760 




. Five images were collected for each sample; each set of images were captured at a 
200-ms exposure time. Images were corrected for differences in laser power by scaling the 
intensities and background noise by subtracting images of illuminated phantoms with no 
fluorophore. 
Representative images of AF 633, IRDye 680RD, and AF750 mixed in the liquid phantoms 
at different concentrations are presented in Figure 8. These images qualitatively 
demonstrate changes in SWIR fluorescence intensities as a result of changing fluorophore 
concentration. A quantitative analysis of the mean fluorescence intensity values for all the 





Figure 8: Representative images of SWIR fluorescence in liquid phantoms containing AF 
633, IRDye 680RD, and AF 750. Each image is a median of five acquisitions.49 
 
 
Figure 9: Fluorescence intensities of liquid fluorophore phantoms with linear fits and 
Pearson’s coefficients. Error bars represent standard deviation. Intensities of fluorophores 





From Figure 9, we can observe that all the tested fluorescent dyes demonstrated some level 
of fluorescence signal that was detectable within the SWIR, even at low concentrations. As 
expected, the fluorophores excited by the 760 nm laser had the greatest signal compared to 
those excited by shorter wavelengths at the same concentrations. These results match the 
integrated fluorescence measurements reported in the spectroscopy study. 
From the spectroscopy and phantom imaging results, AF 750, IRDye 800CW, or ICG 
should be used with either the 760 nm or 785 nm laser. These three NIR-I dyes have the 
highest fluorescence intensities in the phantom imaging compared to the other 
fluorophores. For the SFDI study, ICG was chosen over the other two fluorophores due to 
its clinical relevance. In order to maximize the power of the SFDI projector and 
subsequently the fluorescent signal of ICG, we opted to use the 760 nm laser source in the 
SFDI experiment due to its capability to output greater power than the 785 nm laser. 
4. Comparing NIR-I and SWIR spatial frequency domain imaging   
Due to their ability to improve some aspects of imaging performance, much research has 
taken place to develop SFDI and SWIR imaging, generally on separate tracks. 
Improvements in contrast and resolution using SFDI in the NIR-I have been well-
documented.21,41 Previous work has compared flat light imaging in the NIR-I and SWIR 
when submerged at different depths.23 Additionally, SFDI in the SWIR has been used for 
initial reflectance studies to obtain optical properties of tissues.34 However, to date, SFDI 
of SWIR fluorescence has not been reported and the potential advantages in image contrast 




This study aims to quantify the comparison between SFDI in the NIR-I and SFDI in the 
SWIR. By comparing the demodulated images and flat light images of each optical 
window, we hope to study the efficacy of the SWIR SFDI against the current standard 
techniques. We expect SWIR SFDI to be able to image much deeper fluorescent structures 
than NIR-I SFDI while maintaining similar depth sensitivity and contrast. By measuring 
the differences between various spatial frequencies, we can see how depth sensitivity 
changes when SFDI is used in the SWIR and NIR-I.  Outcomes of this study can be 
translated to clinical applications in order to improve cancer diagnostics and FGS. 
4.1 Theory behind SFDI 
To create the projected spatial patterns in one dimension, the relative intensity of each 
discrete position (Ix) was created from a sinusoid with a DC offset: 
Ix =
1 + cos(2πfxx + α)
2
(3) 
where fx is the spatial frequency (mm










) in one dimension are modeled after the formula: 
IIN = S0Ix (4) 








Figure 10: Illumination patterns for the three phases of a representative spatial frequency. 
 







of a single frequency (see Figure 10). These phase images are subsequently demodulated 
pixel-by-pixel using the following formula: 
𝑀𝐴𝐶(𝑥𝑖, 𝑦𝑖) =
√2((𝐼1 − 𝐼2)2 + (𝐼2 − 𝐼3)2 + (𝐼3 − 𝐼1)2)
3
(5) 
where 𝑀𝐴𝐶(𝑥𝑖, 𝑦𝑖) is the demodulated fluorescence signal at each pixel location (𝑥𝑖, 𝑦𝑖) 
due to the harmonic varying component of the fluorescence images (𝐼𝑛).
32 The combined 
planar fluorescence component (𝑀𝐷𝐶) is obtained from the average of the phase-shifted 
images: 
𝑀𝐷𝐶(𝑥𝑖, 𝑦𝑖) =






For any given frequency at the same depth, 𝑀𝐷𝐶 in (6) represents the image as if it were 
taken with a flat light source.32,45 Hence, 𝑀𝐷𝐶 is expected to be constant for all frequencies 
at a given depth. 
 
Figure 11: Spatial modulation of illumination influences depth sensitivity. Arrows 
represent photons in a turbid medium; the dashed line indicates where the spatial pattern is 
lost due to diffusion. Below the dashed line is the diffuse light. 
 
SFDI can localize structures in tissue because of the unique interactions between the 
modulated illumination and tissue. If the spatial pattern were to be lost due to diffusion in 
tissue, the processed image would disappear due to filtering from (5).21 Figure 11 shows 
the relationship between spatial frequency and depth sensitivity. If the projected spatial 
frequency is high, the maintenance of the pattern is predominantly dependent on the 
scattering properties of tissue.32 Hence, higher spatial frequencies weight the resulting 
image surface since the pattern will quickly become diffuse.41 However, if the projected 
spatial frequency is low, the maintenance of the pattern is primarily dependent on 




less likely to become diffuse. Thus, surgeons can accurately determine whether a structure 
is just below the surface or much deeper in the tissue by changing the spatial frequency. 
4.2 Materials and Experimental Setup 
Based on the conclusions of Section 3, ICG was utilized in this study. In order to prepare 
the fluorophore sample, ICG was first dissolved in deionized water. The absorbance 
spectrum was then taken using the Varian Cary® 50 Bio UV-VIS spectrophotometer to 
calculate the dilution necessary for a 1μM concentration. ICG was then diluted with 
deionized water and 20% intralipid to create a 1 μM ICG solution in 1% intralipid. The 
ICG solution was injected into a plastic tube (OD: 1/8”, ID: 1/16”), which was then placed 
into a 3D printed tube holder and sealed at both ends with black clips (see Figure 12a). The 
tube holder was then placed in a 3D printed bath container. In order to change the depth of 
the tube, a controlled volume of 1% intralipid solution was added to the bath container (see 





Figure 12: a) Schematic of sample. b) Depth (represented by x) was measured from the 
surface of the intralipid bath to the top of the tube. To increase depth, the 1% intralipid bath 
was added. Visual aids on the tube holder ensured accuracy of the depth measurement. c) 





Figure 13: a) Picture of SFDI laser-camera assembly. b) Diagram of SFDI laser-camera 
assembly. 
 
The overall camera-projector assembly is displayed in Figure 13. Light from a 760 nm laser 
source first enters through a 200-𝜇m illumination fiber to a digital micromirror device 
(DMD). Inside the DMD, light reflects off the mirrors to form patterns controlled by a 
computer. These patterns are then reflected to project downwards towards the ICG sample 
in the bath. After the ICG is excited, it emits light back towards the camera-projector 
assembly. The light first hits a dichroic mirror, which splits it by wavelength. Wavelengths 
shorter than 1100 nm will be reflected towards the sCMOS pco.edge 4.2 m camera (PCO) 




long pass filter before hitting the sensor of the PCO camera. Meanwhile, wavelengths 
longer than 1100 nm will be transmitted through the dichroic mirror. The transmitted light 
will then pass through an 1100 nm long pass filter before hitting the sensor of the NIRvana 
camera, which will collect images in the SWIR. Hence, images of the sample can be 
collected in the NIR-I and SWIR concurrently with the same field of view.   
4.3 Data Collection and Analysis 
 
Figure 14: a) The surface of the 1% intralipid bath is illuminated by a laser projected as a 
representative excitation pattern. b) Representative excitation patterns used in the 
experiment. These patterns are projected onto the capillary tube. c) Raw image of the 




Using the camera-projector assembly in Figure 13, NIR-I and SWIR images were taken 
simultaneously using the PCO and NIRvana cameras, respectively. The tube was 
submerged in the bath at: 0, 0.5, 1, 2, 4, and 6 mm. The surface of the 1% intralipid bath 
was excited with 20 unique excitation patterns: flat light, 0.48 mm−1 (3 phases), 0.40 
mm−1 (3 phases), 0.32 mm−1 (3 phases), 0.24 mm−1 (3 phases), 0.16 mm−1 (3 phases), 
0.08 mm−1 (3 phases), and no light (see Figure 14). Both cameras collected 10 frames for 
each of the 20 excitation patterns. Sample acquisition frames at 0 mm depth are 
demonstrated in Figure 14c. For excitation source calibration, the laser power density was 








.  The laser powers recorded for each acquisition are within the same magnitude 
of each other, thus allowing the fluorescence intensities to be compared. Exposure times 
for NIR-I acquisition were set at 300 ms, 600 ms, 900 ms, 1500 ms, 2000 ms, and 2000 ms 
for depths 0 mm, 0.5 mm, 1 mm, 2 mm, 4 mm, and 6 mm, respectively. Exposure times 
for SWIR acquisition were set to 4 seconds for depths 0, 0.5, and 1 mm and 8 seconds for 
depths 2, 4, and 6 mm. NIR-I and SWIR images were collected separately to optimize the 
signal of the tube for post-processing. 
Each frequency-depth-phase combination is made up of 10 raw images. Images were first 
exposure time corrected. Each set of images were divided by the exposure time (in seconds) 
at the respective depth recorded. To reduce the effect of noise, each set of raw images 
(𝐼𝑛,𝑝 | 𝑛 = 1,2, … ,10) was median-filtered for each pixel location (p): 




The median pixels were then combined to create the median-filtered image (𝐼𝑚𝑒𝑑𝑖𝑎𝑛) for 
each frequency-depth-phase combination. To create the DC images necessary to validate 
the image collection procedure, the three phases for each frequency-depth combination 
were inputted into (6). 20 cross-sections of each DC images were taken at the same central 
location. These cross-sections were then median-filtered for analysis. DC images were not 
corrected for background since their purpose is to validate the raw images. To create the 
AC images to test the effects of SFDI, each frequency-depth combination was demodulated 
pixel-by-pixel by inputting the median-filtered images of the three associated phases into 
(5). The output is a frequency-depth image formed by the differences between the three 
phases (i.e. the signals due to the offset of the patterns). 20 cross-sections were taken of 
each AC image at the same central location. These cross-sections were then median-
filtered. Additional background correction of the AC images is unnecessary since (6) 
inherently removes any dark noise and constant signals from ambient light.  
Flat light images were processed in a similar manner for the DC and AC methods. To create 
the DC image, the median flat light image and its respective median background image 






in order to maintain the same magnitude difference. The cross-sections were taken in the 




Median cross-sections of DC images were normalized to the highest value and plotted 
against each other based on depth and optical window to determine similarity. DC images 
that are shown were normalized to the highest value of its median cross-section.  
For AC cross-sections (including flat light), the maximum intensity for each cross-section 
was first recorded. For each frequency, these intensity values were then normalized to the 
intensity at 0 mm and plotted as a function of depth. Exponential curves were then fitted to 
the data points to recover the attenuation coefficient and its 95% confidence interval for 
each frequency. From the fitted exponential curves, theoretical depth thresholds of noise 
falloffs (5% of the signal at the surface for each frequency) were calculated. 
The AC cross-sections were then plotted for each frequency-depth combination to compare 
effects of SFDI on NIR-I and SWIR imaging. Each cross-section was normalized to its 
maximum and centered about its peak to facilitate comparison. AC images demonstrated 
in the results were normalized to its spatial frequency’s maximum cross-sectional value at 
0 mm.  
4.4 Results 
In order to validate the phase images taken for AC demodulation, images of the combined 
planar fluorescence image were calculated using (6) and shown in Figure 15a. The cross-
sectional values for all the frequencies at the recorded depth were also plotted in Figure 
15b. As expected, the cross-sections match in curve shape and magnitude with slight 
variations. The consistency of all frequencies’ DC images matching different depths 
indicate that the phase images for both the SWIR and NIR-I were taken correctly. Thus, 
there should be no significant problems with the demodulated AC images due to 





Figure 15: a) Representative DC images of the fluorescent capillary tube in a 1% intralipid 
bath at 0 mm depth. The representative spatial frequency for these images is 0.24 mm−1. 
b) All frequencies’ median cross-sections at 0 mm depth. The blue band for each image 
consists of 20 cross-sections. Images were normalized to the maximum value of its median 
cross-section. The cross-section comparisons were normalized to the maximum value of 
all frequencies’ cross-sections. 
 
Figure 16 shows representative processed images for flat light imaging and SFDI in the 
NIR-I and SWIR. The representative spatial frequency for the SFDI images is 0.24 mm−1. 
Qualitatively, significant background fluorescence is present in both NIR-I and SWIR flat 
light images, as seen in Figures 16a and 16b. This background fluorescence is not present 
in the NIR-I and SWIR SFDI images (Figures 16c and 16d). Additionally, the SFDI images 
for both optical windows show the tube losing signal relatively quickly compared to the 
flat light images. By 1 mm, both NIR-I and SWIR SFDI tubes are almost indistinguishable 
from the background, whereas signal from the flat light images can still be detected. Hence, 





Figure 16: Processed images for a) NIR-I flat light, b) SWIR flat light, c) NIR-I SFDI, and 
d) SWIR SFDI. SFDI images were taken at a spatial frequency of 0.24 mm-1. Images were 
normalized to the maximum intensity at 0 mm for their respective row. Scale bars in bottom 






Figure 17: a) Representative images of flat light and SFDI images at 0 mm. The spatial 
frequency for the SFDI images is 0.24 mm-1. The blue and red bands show the 20 cross-
sections that were taken for the NIR-I and SWIR, respectively. b) Cross-sections of Figure 
16. The cross-sections were normalized to their respective maximums, centered about their 
peaks, and plotted with respect to depth. 
 
In order to quantify the observations of Figure 16, cross-sections were taken and plotted 
against each other in Figure 17. Figure 17a demonstrates where the cross-sections were 
taken. Figure 17b shows the comparison of the flat light imaging and SFDI cross-sections 
for each optical window. The flat light cross-sections have “shoulders,” or fluorescence 




flat light cross-sections are generally lower than those in the NIR-I. The SFDI cross-
sections, however, do not have shoulders for either optical window. Moreover, SFDI cross-
sections are more noisy than flat light cross-sections, which indicates that the fluorescence 
of the tube is close to intensities of the background. 
The maximum values of all the cross-sections were then plotted against depth for both the 
NIR-I and SWIR for representative frequencies 0.48 𝑚𝑚−1, 0.24 𝑚𝑚−1, and 0.08 𝑚𝑚−1, 
as well as the flat light (see Figure 18). The maximum intensity decreases exponentially as 
the fluorescent sample is submerged deeper into the medium. However, the normalized 
intensities of images captured in the SWIR spectrum were consistently above the NIR-I 
normalized intensities of the same respective frequency and depth. This difference in 
relative intensities indicates that there is an improvement in signal retention when using 





Figure 18: Normalized maximum intensities of cross-sections taken from demodulated 
images for a) flat light, b) 0.08 𝑚𝑚−1, c) 0.24 𝑚𝑚−1, and d) 0.48 𝑚𝑚−1. An exponential 





Figure 19: Representative fitted exponential curve comparisons for NIR-I and SWIR. The 
dashed line represents the 5% threshold where the curve approaches noise falloff (or 
complete disappearance of fluorescence signal). 





For comparison of SFDI and flat light imaging for both optical windows, the fitted 
exponentials for representative frequencies were plotted against depth (Figure 19). The 5% 
threshold depth crossover indicates the cutoff for the deepest a fluorescent object could be 
in a specific medium before the spatial pattern is lost (see Table 1). From Table 1, SWIR 
SFDI has a greater range of depths, as it can reach around ~3 mm depth localization with 
the lowest tested frequency, compared to NIR-I SFDI which can reach around ~1.75 mm 
depth localization.  
5. Discussion 
From the DC image results in Figure 15, it was clear that the data collected is consistent 
with our expectations, i.e., the sum of the three phase images for any spatial frequency 
consistently matched the flat light image at the same depth. If one phase were to be 
significantly brighter than the others, the spatial pattern of that phase would dominate the 
DC reconstructed image. Consequently, this same phase image would dominate the AC 
reconstructed image since it would not evenly cancel out with the other phase images when 
inputted into (5). However, artifacts due to uneven light distribution for a given phase were 
not immediately apparent, indicating that the phases are close to each other in terms of 
intensity. Hence, the image collection process did not contain significant systematic errors 
that would confound results. 
Additionally, the DC image results demonstrate that the same amount of light is present 
for all the different spatial frequencies at the same depth. The flat light image, when 
averaged with the dark light image, has the same amount of light as the average of the three 
phase images. This result demonstrates that the loss of fluorescent signal in AC 




All flat light images in Figures 16a and 16b show significant background fluorescence. 
Although the tube is only 3.175 mm wide, the flat light cross-sections in Figure 17b show 
some fluorescence signal over an estimated 20 mm for both the NIR-I and SWIR. This 
background fluorescence limits applications of flat light imaging, especially since it can 
blur multiple structures in an image. Although SWIR flat light images have less 
background fluorescence, the accumulation of signal can interfere with determining the 
shape and depth of overlapping structures.51 
SFDI images are significantly sharper, and the cross-sections of both NIR-I and SWIR 
images in Figure 17b show fluorescence signals within a 4 mm span (as compared to the 
20 mm span of the flat light cross-sections). Hence, optical window does not factor into 
SFDI’s ability to filter background fluorescence. This finding is significant because a key 
advantage of SWIR was lower light scatter and consequently higher resolution.3 SFDI 
effectively removes background fluorescence such that NIR-I and SWIR images are now 
comparable in sharpness.  
Although SFDI images improved contrast, they did introduce artifacts. For instance, 
Figures 16(c) and 16(d) show images that are patterned instead of flat. These patterns are 
most likely the result of demodulating flawed phase images. Problems with the phase 
images could be caused by low camera resolution or uneven laser excitement. 
The PCO camera used to capture NIR-I images had a 2048 pixels x 2048 pixels sensor. 
However, due to the physical setup, only 43 pixels captured the width of the fluorescence 
sample. The same problem is true for the NIRvana, which only used 15 pixels out of the 
possible 512. As a result, there is room to reduce the field of view such as to increase 




fluorescent sample without sacrificing the focus. One way to implement this improvement 
is to change the lens combinations such that the image of the sample occupies a larger part 
of the field of view. Another possible improvement is to move the camera closer. This 
experiment was unable to move the camera closer since the laser illumination would not 
have been able to reach the target. 
The other potential problem, uneven laser excitement, could be remedied by a flatfield 
image correction, i.e., the raw images are first divided by the respective images of a flat 
planar surface. A reflectance standard was imaged for this purpose. However, the collected 
flatfield images that were collected as part of this experiment introduced more artifacts 
when applied, and thus the correction was omitted from the data processing. One possible 
improvement would be to image the surface of a 1μM ICG and 1% intralipid bath.21 As a 
result, the fluorescence would be recorded by both the NIR-I and SWIR cameras, and the 
data could then be flatfield corrected. 
Figure 19 shows that SWIR SFDI has greater signal retention than SFDI in the NIR-I. The 
values in Table 1 shows the theoretical limits of each spatial frequency. This would be 
important for low spatial frequencies since it allows the surgeon to see deeper structures 
than NIR-I at the same spatial frequencies. Although SWIR SFDI can image at a greater 
range of depths, it is not as depth sensitive as NIR-I SFDI. NIR-I SFDI, at the highest 
frequencies, has a large intensity change over less than 1 mm. On the other hand, SWIR 
SFDI only filters out fluorescent structures below 1.3-1.7 mm into tissue. This is significant 
because NIR-I SFDI can better locate fluorescent structures on the surface. One possible 
solution to improve SWIR’s depth sensitivity is to use even higher spatial frequencies (such 




resolution before it begins creating discrete, rather than continuous, waves. Moreover, the 
SWIR camera may not be able to resolve these higher spatial frequencies. Table 1 shows 
that increasing the spatial frequency past 0.24 mm−1 had minimal effect. Overall, SWIR 
SFDI can image deeper fluorescence, but NIR-I SFDI is more sensitive to surface 
structures. 
6. Conclusions 
This study demonstrated that SFDI in the SWIR can significantly improve depth 
localization and contrast of the fluorescence structure compared to SWIR flat light 
imaging. Both NIR-I and SWIR SFDI were able to filter out deep-seeded fluorescence and 
improve resolution. From the results of this study, NIR-I SFDI was more depth sensitive 
and thus can better localize structures near the tissue surface. Nevertheless, SWIR SFDI 
can still accurately localize fluorescence in tissue. Moreover, SWIR SFDI could detect 
fluorescent objects at much deeper levels compared to NIR-I. Thus, SWIR SFDI is an 
improvement over conventional flat light imaging and offers a competitive alternative to 
NIR-I SFDI. 
Future work in SWIR SFDI could investigate the effects from altering the optical properties 
of the phantom, the interaction between multiple fluorescence sources, and in vivo efficacy 
studies. These experiments would further validate SWIR SFDI’s effectiveness and 
motivate translation to clinical use. 
Overall, SWIR SFDI is a readily accessible alternative that can be quickly implemented 
into current SWIR biomedical applications such as FGS. By improving image quality and 




significantly change the way surgeries are performed. With this new technique, we can 
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